New Sodium-Glucose Transporter 2 Inhibitors Study Findings Recently Were Reported by a Researcher at Charite - University Medicine Berlin (Reno-protective Effects of Empagliflozin are linked to Activation of the Tubuloglomerular Feedback ...).
Předmět: | |
---|---|
Zdroj: | Diabetes Week; 2/27/2023, p178-178, 1p |
Databáze: | Complementary Index |
Externí odkaz: |